Status:
WITHDRAWN
Study of LUNG Stereotactic Adaptive Ablative Radiotherapy
Lead Sponsor:
Baptist Health South Florida
Conditions:
Lung Cancer
Lung Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The proposed study expands on the principles of SBRT (Stereotactic Body Radiation Therapy) and SABR (Stereotactic Ablative Radiotherapy) for centrally located NSCLC (Non-Small Cell Lung Cancer) to fur...
Eligibility Criteria
Inclusion
- Age ≥ 18 years of age
- Clinical diagnosis of NSCLC
- Stage T1-2b (≤ 5 cm)
Exclusion
- Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 1 year (i.e., carcinomas in situ of the breast, oral cavity, or cervix are permissible); previous lung cancer, if the patient is disease-free for a minimum of 1 year is permitted;
- Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
- Prior chemotherapy for the study cancer
- Plans for the patient to receive other local therapy (including standard fractionated radiotherapy and/or surgery) while on this study, except at disease progression
- Plans for the patient to receive systemic therapy (including standard chemotherapy or biologic targeted agents), while on this study, except at disease progression
Key Trial Info
Start Date :
May 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2032
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04917224
Start Date
May 2 2022
End Date
October 1 2032
Last Update
September 26 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.